Author Bandelow, Borwin

1 to 100 of 153 Items

2000 | Conference Abstract
Responsiveness of central serotonin receptors in panic disorder: Effects of clomipramine treatment and exercise
Broocks, A.; Ruther, E.; Munzel, U.; Hajak, G.; Wedekind, D. & Bandelow, B. (2000)
European Psychiatry, 15
Paris cedex 15: Editions Scientifiques Medicales Elsevier. DOI: https://doi.org/10.1016/S0924-9338(00)94044-6
Details DOI WoS

2000 | Journal Article
The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial
Bandelow, B.; Broocks, A.; Pekrun, G.; George, A.; Meyer, T.; Pralle, L. & Bartmann, U. et al. (2000)
Pharmacopsychiatry, 33(5) pp. 174-181. DOI: https://doi.org/10.1055/s-2000-12982
Details DOI PMID PMC WoS

2000 | Journal Article | Letter Note
Myocarditis associated with clozapine treatment
Degner, D.; Bleich, S.; Grohmann, R.; Bandelow, B. & Ruther, E. (2000)
Australian and New Zealand Journal of Psychiatry, 34(5). DOI: https://doi.org/10.1080/j.1440-1614.2000.0822n.x
Details DOI PMID PMC WoS

2000 | Journal Article
Advances in the pharmacotherapy of depression by new antidepressants
Broocks, A.; Junghanns, K.; Thiel, A.; Gleiter, C. H. & Bandelow, B. (2000)
Fortschritte der Neurologie · Psychiatrie, 68(1) pp. 17-24. DOI: https://doi.org/10.1055/s-2000-11639
Details DOI PMID PMC WoS

2000 | Journal Article
Confusion and excitability of initially undetermined cause in the course of poisoning with deadly nightshade in attempted suicide: symptoms, differential diagnosis, toxicology and physostigmine treatment of an anticholinergic syndrome
Heindl, S.; Binder, C.; Desel, H.; Matthies, U.; Lojewski, I.; Bandelow, B. & Kahl, G. F. et al. (2000)
DMW - Deutsche Medizinische Wochenschrift, 125(45) pp. 1361-1365. DOI: https://doi.org/10.1055/s-2000-8178
Details DOI PMID PMC WoS

2000 | Journal Article
Polymorphism of the gene of angiotensin converting enzyme: lack of association with mood disorder
Pauls, J.; Bandelow, B.; Ruther, E. & Kornhuber, J. (2000)
Journal of Neural Transmission, 107(11) pp. 1361-1366. DOI: https://doi.org/10.1007/s007020070023
Details DOI PMID PMC WoS

2000 | Journal Article
Salivary, total plasma and plasma free cortisol in panic disorder
Wedekind, D.; Bandelow, B.; Broocks, A.; Hajak, G. & Ruther, E. (2000)
Journal of Neural Transmission, 107(7) pp. 831-837. DOI: https://doi.org/10.1007/s007020070062
Details DOI PMID PMC WoS

2000 | Journal Article
Plasma homocysteine is a predictor of alcohol withdrawal seizures
Bleich, S.; Degner, D.; Bandelow, B.; von Ahsen, N.; Ruther, E. & Kornhuber, J. (2000)
Neuroreport, 11(12) pp. 2749-2752. DOI: https://doi.org/10.1097/00001756-200008210-00028
Details DOI PMID PMC WoS

2000 | Journal Article
Diurnal variation of cortisol in panic disorder
Bandelow, B.; Wedekind, D.; Sandvoss, V.; Broocks, A.; Hajak, G.; Pauls, J. & Peter, H. et al. (2000)
Psychiatry Research, 95(3) pp. 245-250. DOI: https://doi.org/10.1016/S0165-1781(00)00183-9
Details DOI PMID PMC WoS

2000 | Journal Article
Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder
Broocks, A.; Bandelow, B.; George, A.; Jestrabeck, C.; Opitz, M.; Bartmann, U. & Gleiter, C. H. et al. (2000)
International Clinical Psychopharmacology, 15(3) pp. 153-161. DOI: https://doi.org/10.1097/00004850-200015030-00004
Details DOI PMID PMC WoS

2001 | Journal Article
Generalized anxiety disorders - A neglected illness? Background and aims of the GAD-P-Study
Wittchen, H.-U.; Linden, M.; Schwarzer, W.; Riemann, D.; Boerner, R. J. & Bandelow, B. (2001)
MMW-FORTSCHRITTE DER MEDIZIN, pp. 1-4.
Details WoS

2001 | Conference Abstract
Increased psychobehavioral responsiveness to M-chlorophenylpiperazine (m-CPP) and ipsapirone (IPS) in patients with panic disorder (PDA)
Broocks, A.; Bandelow, B.; George, A. & Roed, I. S. (2001)
Journal of Neurochemistry, 78
Oxford: Blackwell Science Ltd.
Details WoS

2001 | Journal Article
Separation anxiety and actual separation experiences during childhood in patients with panic disorder
Bandelow, B.; Tichauer, G. A.; Spath, C.; Broocks, A.; Hajak, G.; Bleich, S. & Ruther, E. (2001)
The Canadian Journal of Psychiatry, 46(10) pp. 948-952.
Details PMID PMC WoS

2001 | Journal Article
Cortisol in night-urine: Introduction of a research method in psychoneuroendocrinology
Doering, S.; Wedekind, D.; Pilz, J.; Bandelow, B.; Adler, L. & Huether, G. (2001)
ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 47(1) pp. 42-57.
Details PMID PMC WoS

2001 | Journal Article
Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects
Broocks, A.; Meyer, T.; Gleiter, C. H.; Hillmer-Vogel, U.; George, A.; Bartmann, U. & Bandelow, B. (2001)
Psychopharmacology, 155(3) pp. 234-241. DOI: https://doi.org/10.1007/s002130100706
Details DOI PMID PMC WoS

2002 | Conference Abstract
How long to treat anxiety disorders?
Bandelow, B. (2002)
European Neuropsychopharmacology, 12 pp. S159-S160.
Amsterdam: Elsevier Science Bv.
Details WoS

2002 | Conference Abstract
Sertraline versus paroxetine in the treatment of panic disorder: A multinational randomized double-blind 15 week study
Bandelow, B.; Behnke, K.; Lenoir, S.; Hendriks, G. J.; Alkin, T.; Dombrowski, A. & Goebel, C. (2002)
European Neuropsychopharmacology, 12
Amsterdam: Elsevier Science Bv.
Details WoS

2002 | Conference Abstract
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder
Broocks, A.; Hajak, G.; Bandelow, B.; Koch, K.; Schweiger, U. & Hohagen, F. (2002)
European Psychiatry, 17
Paris cedex 15: Editions Scientifiques Medicales Elsevier.
Details WoS

2002 | Journal Article
Quick sedation of the agitated patient with zyprexa velotab - Innovation in acute psychiatric care
Bandelow, B. (2002)
NERVENHEILKUNDE, 21(5) pp. 75-76.
Details WoS

2002 | Journal Article
Evaluating the efficacy of psychological therapy
Bandelow, B. & Broocks, A. (2002)
Verhaltenstherapie, 12(3) pp. 205-215. DOI: https://doi.org/10.1159/000066571
Details DOI WoS

2002 | Journal Article
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with panic disorder
Bandelow, B.; Spath, C.; Tichauer, G. A.; Broocks, A.; Hajak, G. & Ruther, E. (2002)
Comprehensive Psychiatry, 43(4) pp. 269-278. DOI: https://doi.org/10.1053/comp.2002.33492
Details DOI PMID PMC WoS

2002 | Journal Article
Assessing the severity of panic disorder and agoraphobia: Validity, reliability and objectivity of the Turkish translation of the Panic and Agoraphobia Scale (P&A)
Tural, U.; Fidaner, H.; Alkin, T. & Bandelow, B. (2002)
Journal of Anxiety Disorders, 16(3) art. PII S0887-6185(02)00104-4. DOI: https://doi.org/10.1016/S0887-6185(02)00104-4
Details DOI PMID PMC WoS

2002 | Journal Article
Smoking modulates neuroendocrine responses to ipsapirone in patients with panic disorder
Broocks, A.; Bandelow, B.; Koch, K.; Bartmann, U.; Kinkelbur, J.; Schweiger, U. & Hohagen, F. et al. (2002)
Neuropsychopharmacology, 27(2) art. PII S0893-133X(02)00298-1. DOI: https://doi.org/10.1016/S0893-133X(02)00298-1
Details DOI PMID PMC WoS

2003 | Conference Abstract
Relevance of therapeutic drug monitoring (TDM) in patients with quetiapine administration
Degner, D.; Bandelow, B.; Akkan, R.; Kropp, S.; Nietmann, P. D.; Ruther, E. & Bleich, S. (2003)
Pharmacopsychiatry, 36(5) 23rd Symposium of the Arbeitsgemeinschaft-Neuropsychopharmakologie-und-Pharmakopsychiatrie (AGNP), MUNICH, GERMANY.
Stuttgart: Georg Thieme Verlag Kg.
Details WoS

2003 | Journal Article
5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo
Broocks, A.; Meyer, T.; Opitz, M.; Bartmann, U.; Hillmer-Vogel, U.; George, A. & Pekrun, G. et al. (2003)
European Neuropsychopharmacology, 13(3) pp. 153-164. DOI: https://doi.org/10.1016/S0924-977X(02)00177-3
Details DOI PMID PMC WoS

2003 | Journal Article
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholism
Bleich, S.; Bandelow, B.; Javaheripour, K.; Mueller, A.; Degner, D.; Wilhelm, J. & Havemann-Reinecke, U. et al. (2003)
Neuroscience Letters, 335(3) art. PII S0304-3940(02)01194-1. DOI: https://doi.org/10.1016/S0304-3940(02)01194-1
Details DOI PMID PMC WoS

2004 | Review
Treatment-resistant panic disorder
Bandelow, B.& Ruther, E. (2004)
CNS Spectrums, 9(10) pp. 725-+.
M B L Communications, Inc.
Details PMID PMC WoS

2004 | Conference Abstract
Escitalopram in the treatment of anxiety symptoms associated with depression
Bandelow, B. & Andersen, H. (2004)
Neuropsychopharmacology, 29 Annual Meeting of the American-College-of-Neuropsychopharmacology, San Juan, PR.
London: Nature Publishing Group.
Details WoS

2004 | Journal Article
Sertraline versus paroxetine in the treatment of panic disorder: An acute, double-blind noninferiority comparison
Bandelow, B.; Behnke, K.; Lenoir, S.; Hendriks, G. J.; Alkin, T.; Goebel, C. & Clary, C. M. (2004)
The Journal of Clinical Psychiatry, 65(3) pp. 405-413.
Details PMID PMC WoS

2004 | Journal Article
Acute agranulocytosis after long-term clozapine treatment
Degner, D.; Knievel, A.; Mueller, P.; Bandelow, B.; Schaefer, E.; Grohmann, R. & Ruther, E. (2004)
PSYCHOPHARMAKOTHERAPIE, 11(3) pp. 98-100.
Details WoS

2004 | Journal Article | Letter Note
Sertraline and exposure therapy in social phobia
Bandelow, B. (2004)
The British Journal of Psychiatry, 184. DOI: https://doi.org/10.1192/bjp.184.3.271
Details DOI PMID PMC WoS

2004 | Journal Article
Early traumatic life events, parental rearing styles, family history of mental disorders, and birth risk factors in patients with social anxiety disorder
Bandelow, B.; Torrente, A. C.; Wedekind, D.; Broocks, A.; Hajak, G. & Ruther, E. (2004)
European Archives of Psychiatry and Clinical Neuroscience, 254(6) pp. 397-405. DOI: https://doi.org/10.1007/s00406-004-0521-2
Details DOI PMID PMC WoS

2005 | Conference Abstract
Investigation of RGS2 and RGS13 gene polymorphisms in human panic disorder
Hohoff, C.; Jung, A.; Freitag, C. M.; Willis-Owen, S. A.; Ponath, G.; Krakowitzky, P. & Fritze, J. et al. (2005)
American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 138B(1) 13th World Congress on Psychiatric Genetics, Boston, MA.
Hoboken: Wiley-liss.
Details WoS

2005 | Journal Article
Oculogyric crisis under aripiprazol in combination with fluoxetin
Degner, D.; Fiege, O.; Bandelow, B.; Grohmann, R. & Ruther, E. (2005)
PSYCHOPHARMAKOTHERAPIE, 12(1) pp. 32-33.
Details WoS

2005 | Conference Abstract
Treatment of anxiety disorders
Bandelow, B. (2005)
European Neuropsychopharmacology, 15 8th Regional Meeting of the European Congress of Neuropathology, Moscow, RUSSIA.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(05)80218-4
Details DOI WoS

2005 | Conference Abstract
Treating anxiety disorders: Efficacy and safety considerations
Bandelow, B. (2005)
European Psychiatry, 20 pp. S153-S154.
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2005 | Conference Abstract
Escitalopram in the treatment of anxiety symptoms associated with depression
Bandelow, B. (2005)
European Psychiatry, 20
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2005 | Conference Abstract
Treatment of panic anxiety disorder: An update
Bandelow, B. (2005)
European Psychiatry, 20
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2005 | Journal Article
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia
Naber, D.; Riedel, M.; Klimke, A.; Vorbach, E. U.; Lambert, M.; Kuhn, K. U. & Bender, S. et al. (2005)
Acta Psychiatrica Scandinavica, 111(2) pp. 106-115. DOI: https://doi.org/10.1111/j.1600-0447.2004.00486.x
Details DOI PMID PMC WoS

2005 | Journal Article
Early traumatic life events, parental attitudes, family history, and birth risk factors in patients with borderline personality disorder and healthy controls
Bandelow, B.; Krause, J.; Wedekind, D.; Broocks, A.; Hajak, G. & Ruther, E. (2005)
Psychiatry Research, 134(2) pp. 169-179. DOI: https://doi.org/10.1016/j.psychres.2003.07.008
Details DOI PMID PMC WoS

2005 | Review
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Baldwin, D. S.; Anderson, I. M.; Nutt, D. J.; Bandelow, B.; Bond, A.; Davidson, J.& den Boer, J. A. et al. (2005)
Journal of Psychopharmacology, 19(6) pp. 567-596.
Sage Publications Ltd. DOI: https://doi.org/10.1177/0269881105059253
Details DOI PMID PMC WoS

2005 | Journal Article
Pharmacotherapy in personality disorders
Wedekind, D.; Bandelow, B. & Ruther, E. (2005)
Fortschritte der Neurologie · Psychiatrie, 73(5) pp. 259-267. DOI: https://doi.org/10.1055/s-2004-830107
Details DOI PMID PMC WoS

2005 | Journal Article
Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges
Kronenberg, G.; Berger, P.; Tauber, R. F.; Bandelow, B.; Henkel, V. & Heuser, I. (2005)
Pharmacopsychiatry, 38(1) pp. 24-29. DOI: https://doi.org/10.1055/s-2005-837768
Details DOI PMID PMC WoS

2005 | Journal Article
The alpha(2)delta subunit off the tension-dependent calcium channel
Wedekind, D. & Bandelow, B. (2005)
Der Nervenarzt, 76(7) pp. 888-891. DOI: https://doi.org/10.1007/s00115-005-1940-7
Details DOI PMID PMC WoS

2006 | Journal Article
Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram
Stein, D. J.; Baldwin, D. S.; Dolberg, O. T.; Despiegel, N. & Bandelow, B. (2006)
The Journal of Clinical Psychiatry, 67(11) pp. 1741-1746.
Details PMID PMC WoS

2006 | Conference Abstract
Which factors predict placebo response in anxiety disorders and major depression?
Stein, D. J.; Baldwin, D. S.; Dolberg, O. T.; Despiegel, N. & Bandelow, B. (2006)
European Neuropsychopharmacology, 16 19th Congress of the European-College-of-Neuropsychopharmacology, Paris, FRANCE.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70618-6
Details DOI WoS

2006 | Conference Abstract
Generalized anxiety disorder (GAD): the treatment implications of clinical heterogeneity
Bandelow, B. (2006)
European Neuropsychopharmacology, 16 19th Congress of the European-College-of-Neuropsychopharmacology, Paris, FRANCE.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(06)70835-5
Details DOI WoS

2006 | Journal Article
Defining response and remission in anxiety disorders: Toward an integrated approach
Bandelow, B. (2006)
CNS Spectrums, 11(10) pp. 21-28.
Details PMID PMC WoS

2006 | Journal Article
Anxiety disorders: Long-term treatment and relapse prevention
Bandelow, B.; Wolff-Menzler, C.; Wedekind, D. & Ruther, E. (2006)
MMW-FORTSCHRITTE DER MEDIZIN, 148(4) pp. 31-34.
Details PMID PMC WoS

2006 | Journal Article
Rgs 2 gene polymorphisms as modulators of anxiety in humans?
Leygraf, A.; Hohoff, C.; Freitag, C. M.; Willis-Owen, S. A.; Krakowitzky, P.; Fritze, J. & Franke, P. E. et al. (2006)
Journal of Neural Transmission, 113(12) pp. 1921-1925. DOI: https://doi.org/10.1007/s00702-006-0484-8
Details DOI PMID PMC WoS

2006 | Journal Article
What Is the Threshold for Symptomatic Response and Remission for Major Depressive Disorder, Panic Disorder, Social Anxiety Disorder, and Generalized Anxiety Disorder?
Bandelow, B.; Baldwin, D. S.; Dolberg, O. T.; Andersen, H. F. & Stein, D. J. (2006)
The Journal of Clinical Psychiatry, 67(9) pp. 1428-1434. DOI: https://doi.org/10.4088/JCP.v67n0914
Details DOI PMID PMC WoS

2006 | Journal Article
Panic disorder during pregnancy and postpartum period
Bandelow, B.; Sojka, F.; Broocks, A.; Hajak, G.; Bleich, S. & Ruether, E. (2006)
European Psychiatry, 21(7) pp. 495-500. DOI: https://doi.org/10.1016/j.eurpsy.2005.11.005
Details DOI PMID PMC WoS

2007 | Conference Abstract
Treatment-resistant panic anxiety disorder
Bandelow, B. (2007)
European Neuropsychopharmacology, 17 pp. S207-S208. 20th Congress of the European-College-of-Neuropsychopharmacology, Vienna, AUSTRIA.
Amsterdam: Elsevier Science Bv. DOI: https://doi.org/10.1016/S0924-977X(07)70257-2
Details DOI WoS

2007 | Review
Drug treatment of generalized anxiety disorder (GAD) - a consensus statement
Bandelow, B.; Boerner, R. J.; Kasper, S.; Linden, M.; Volz, H.-P.; Wittchen, H.-U.& Moeller, H.-J. (2007)
PSYCHOPHARMAKOTHERAPIE, 14(4) pp. 136-+.
Wissenschaftliche Verlag Mbh.
Details WoS

2007 | Conference Abstract
Controlled study for effectiveness of sport vs. relaxation training in combination with paroxetine vs. Placebo in the treatment of the panic disorder
Wedekind, D.; Broocks, A.; Weiss, N.; Rotter-Glattkowski, P.; Engel, K.; Neubert, K. & Bandelow, B. (2007)
Der Nervenarzt, 78
New york: Springer.
Details WoS

2007 | Conference Abstract
New therapy options for anxiety and compulsive disorder
Bandelow, B. (2007)
Der Nervenarzt, 78
New york: Springer.
Details WoS

2007 | Conference Abstract
Therapy of fear disorder
Bandelow, B. (2007)
Der Nervenarzt, 78
New york: Springer.
Details WoS

2007 | Conference Abstract
Results from a phase III study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder
Bandelow, B.; Bobes, J.; Ahokas, A.; Eggens, I.; Liu, S. & Brecher, M. (2007)
International Journal of Psychiatry in Clinical Practice, 11(4) pp. 314-315.
Oslo: Taylor & Francis As.
Details WoS

2007 | Journal Article
Treatment of obsessive-compulsive disorder
Stein, D. J.; Ipser, J. C.; Baldwin, D. S. & Bandelow, B. (2007)
CNS Spectrums, 12(2) pp. 28-35.
Details WoS

2007 | Conference Abstract
Long term treatment of anxiety disorders
Bandelow, B. (2007)
European Psychiatry, 22
Paris: Elsevier France-editions Scientifiques Medicales Elsevier. DOI: https://doi.org/10.1016/j.eurpsy.2007.01.282
Details DOI WoS

2007 | Conference Abstract
Pharmacological treatment of anxiety disorders - is there a state of the art
Bandelow, B. (2007)
European Psychiatry, 22
Paris: Elsevier France-editions Scientifiques Medicales Elsevier. DOI: https://doi.org/10.1016/j.eurpsy.2007.01.1169
Details DOI WoS

2007 | Conference Abstract
Prevalence of pain in depression
Bandelow, B. (2007)
International Journal of Psychiatry in Clinical Practice, 11(4)
Oslo: Taylor & Francis As.
Details WoS

2007 | Journal Article | Letter Note
More on placebo response - Reply
Stein, D. J.; Baldwin, D. S.; Dolberg, O. T.; Despiegel, N. & Bandelow, B. (2007)
The Journal of Clinical Psychiatry, 68(12) pp. 1984-1985.
Details WoS

2007 | Journal Article
Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo
Bandelow, B.; Stein, D. I.; Dolberg, O. T.; Andersen, H. F. & Baldwin, D. S. (2007)
Pharmacopsychiatry, 40(4) pp. 152-156. DOI: https://doi.org/10.1055/s-2007-984398
Details DOI PMID PMC WoS

2007 | Journal Article
Escitalopram in the treatment of anxiety symptoms associated with depression
Bandelow, B.; Andersen, H. F. & Dolberg, O. T. (2007)
Depression and Anxiety, 24(1) pp. 53-61. DOI: https://doi.org/10.1002/da.20141
Details DOI PMID PMC WoS

2007 | Review
Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders
Bandelow, B.; Seidler-Brandler, U.; Becker, A.; Wedekind, D.& Ruether, E. (2007)
The World Journal of Biological Psychiatry, 8(3) pp. 175-187.
Taylor & Francis Ltd. DOI: https://doi.org/10.1080/15622970601110273
Details DOI PMID PMC WoS

2007 | Journal Article
The quantification inventory for somatoform syndromes MISS): a novel instrument for the assessment of severity
Wedekind, D.; Bandelow, B.; Fentzahn, E.; Truemper, P. & Ruether, E. (2007)
European Archives of Psychiatry and Clinical Neuroscience, 257(3) pp. 153-163. DOI: https://doi.org/10.1007/s00406-006-0700-4
Details DOI PMID PMC WoS

2008 | Conference Abstract
How are symptom severity and functional recovery/relapse related? An analysis of the escitalopram database
Stein, D. J.; Bandelow, B.; Dolberg, O. T.; Andersen, H. F. & Baldwin, D. S. (2008)
European Psychiatry, 23
Paris: Elsevier France-editions Scientifiques Medicales Elsevier. DOI: https://doi.org/10.1016/j.eurpsy.2008.01.1279
Details DOI WoS

2008 | Conference Abstract
Serotonergic function, substance craving, and psychopathology in detoxified alcohol addicted males undergoing tryptophane depletion
Wedekind, D.; Herchenhein, T.; Kirchhainer, S.; Bandelow, B.; Engel, K.; Malchow, B. & Falkai, P. G. et al. (2008)
The International Journal of Neuropsychopharmacology, 11 26th Collegium Internationale Neuro-Psychopharmacologicum Congress (CINP), Munich, GERMANY.
New york: Cambridge Univ Press.
Details WoS

2008 | Journal Article
The Medical Treatment of Obssessive-Compulsive Disorder and Anxiety
Bandelow, B. (2008)
CNS Spectrums, 13(9) pp. 37-46.
Details PMID PMC WoS

2008 | Journal Article
Social Anxiety Disorder - Diagnostics and Treatment Options
Wedekind, D.; Engel, K. & Bandelow, B. (2008)
Fortschritte der Neurologie · Psychiatrie, 76(10) pp. 616-620. DOI: https://doi.org/10.1055/s-2008-1038201
Details DOI PMID PMC WoS

2008 | Review
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Bandelow, B.; Zohar, J.; Hollander, E.; Kasper, S.; Moeller, H.-J.; Allgulander, C.& Ayuso-Gutierrez, J. et al. (2008)
The World Journal of Biological Psychiatry, 9(4) pp. 248-312.
Taylor & Francis Ltd. DOI: https://doi.org/10.1080/15622970802465807
Details DOI PMID PMC WoS

2008 | Journal Article | Letter Note
How to grade categories of evidence
Bandelow, B.; Zohar, J.; Kasper, S. & Moeller, H.-J. (2008)
The World Journal of Biological Psychiatry, 9(4) pp. 242-247. DOI: https://doi.org/10.1080/15622970802456590
Details DOI PMID PMC WoS

2008 | Journal Article | Letter Note
Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks
Erhardt, A.; Lucae, S.; Kern, N.; Unschuld, P. G.; Ising, M.; Lieb, R. & Uhr, M. et al. (2008)
Molecular Psychiatry, 13(3) pp. 242-243. DOI: https://doi.org/10.1038/sj.mp.4002094
Details DOI PMID PMC WoS

2008 | Review
Nocturnal Urinary Cortisol Excretion Over a Randomized Controlled Trial with Paroxetine vs. Placebo Combined with Relaxation Training or Aerobic Exercise in Panic Disorder
Wedekind, D.; Sprute, A.; Broocks, A.; Huether, G.; Engel, K.; Falkai, P. G.& Bandelow, B. (2008)
Current Pharmaceutical Design, 14(33) pp. 3518-3524.
Bentham Science Publ Ltd. DOI: https://doi.org/10.2174/138161208786848757
Details DOI PMID PMC WoS

2008 | Journal Article
Chromosome 4q31-34 panic disorder risk locus: Association of neuropeptide YY5 receptor variants
Domschke, K.; Hohoff, C.; Jacob, C. P.; Maier, W.; Fritze, J.; Bandelow, B. & Krakowitzky, P. et al. (2008)
American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 147B(4) pp. 510-516. DOI: https://doi.org/10.1002/ajmg.b.30629
Details DOI PMID PMC WoS

2008 | Journal Article
Combined Effects of Exonic Polymorphisms in CRHR1 and AVPR1B Genes in a Case/Control Study for Panic Disorder
Keck, M. E.; Kern, N.; Erhardt, A.; Unschuld, P. G.; Ising, M.; Salyakina, D. & Mueller, M. B. et al. (2008)
American Journal of Medical Genetics Part B Neuropsychiatric Genetics, 147B(7) pp. 1196-1204. DOI: https://doi.org/10.1002/ajmg.b.30750
Details DOI PMID PMC WoS

2009 | Conference Abstract
Clinical suitability of GAD-7 scale compared to hospital anxiety and depression scale-A for monitoring treatment effects in generalized anxiety disorder
Bandelow, B. & Brasser, M. (2009)
European Neuropsychopharmacology, 19 pp. S604-S605. 22nd Congress of the European-College-of-Neuropsychopharmacology, Istanbul, TURKEY.
Amsterdam: Elsevier Science Bv.
Details WoS

2009 | Conference Abstract
Benzodiazepines and Pregabalin in the Treatment of Generalized Anxiety Disorder
Bandelow, B. (2009)
International Journal of Psychiatry in Clinical Practice, 13
Oslo: Taylor & Francis As.
Details WoS

2009 | Conference Abstract
Long-term treatment of anxiety disorders
Bandelow, B. (2009)
International Journal of Psychiatry in Clinical Practice, 13
Oslo: Taylor & Francis As.
Details WoS

2009 | Journal Article | Letter Note
Remission of Acute Psychotic Anxious Depression in a Patient with Parkinson's Disease After Treatment with Quetiapine
Link, S.; Paulus, W. J. & Bandelow, B. (2009)
Movement Disorders, 24(16) pp. 2431-2432. DOI: https://doi.org/10.1002/mds.22846
Details DOI PMID PMC WoS

2009 | Conference Abstract
Symptom improvement and functional recovery in patients with anxiety disorders
Baldwin, D. S.; Bandelow, B.; Dolberg, O. T.; Andersen, H. F. & Stein, D. J. (2009)
European Neuropsychopharmacology, 19 pp. S590-S591. 22nd Congress of the European-College-of-Neuropsychopharmacology, Istanbul, TURKEY.
Amsterdam: Elsevier Science Bv.
Details WoS

2009 | Journal Article
Effectiveness and tolerability of pregabalin in patients with generalized anxiety disorders in routine clinical care
Moeller, H.-J.; Brasser, M.; Kasper, S.; Volz, H.-P.; Boerner, R. J. & Bandelow, B. (2009)
PSYCHOPHARMAKOTHERAPIE, 16(5) pp. 211-+.
Details WoS

2009 | Journal Article
Anxiety symptom severity and functional recovery or relapse
Stein, D. J.; Bandelow, B.; Dolberg, O. T.; Andersen, H. F. & Baldwin, D. S. (2009)
Annals of Clinical Psychiatry, 21(2) pp. 81-88.
Details PMID PMC WoS

2009 | Conference Abstract
Comorbid depression and anxiety - understanding and treating complex patients
Bandelow, B. (2009)
European Neuropsychopharmacology, 19 22nd Congress of the European-College-of-Neuropsychopharmacology, Istanbul, TURKEY.
Amsterdam: Elsevier Science Bv.
Details WoS

2009 | Journal Article
Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
Kasper, S.; Herman, B.; Nivoli, G.; van Ameringen, M.; Petralia, A.; Mandel, F. S. & Baldinetti, F. et al. (2009)
International Clinical Psychopharmacology, 24(2) pp. 87-96. DOI: https://doi.org/10.1097/YIC.0b013e32831d7980
Details DOI PMID PMC WoS

2009 | Journal Article
Atypical Anorexia in a Male Patient Accompanied by Strong Obsessive-compulsive Symptoms Successfully Treated with Naltrexone
Gade, K.; Haeussinger, C. & Bandelow, B. (2009)
Pharmacopsychiatry, 42(4) pp. 164-165. DOI: https://doi.org/10.1055/s-0028-1128114
Details DOI PMID PMC WoS

2009 | Conference Paper
Association analysis of Rgs7 variants with panic disorder
Hohoff, C.; Neumann, A.; Domschke, K.; Jacob, C. P.; Maier, W.; Fritze, J. & Bandelow, B. et al. (2009)
Journal of Neural Transmission, 116(11) pp. 1523-1528. Interacademic Symposium on Neurobiology of Neuro-Psychiatric Diseases, Jerusalem, ISRAEL.
Wien: Springer. DOI: https://doi.org/10.1007/s00702-008-0097-5
Details DOI PMID PMC WoS

2009 | Review |
Neuroimaging in anxiety disorders
Engel, K.; Bandelow, B.; Gruber, O.& Wedekind, D. (2009)
Journal of Neural Transmission, 116(6) pp. 703-716.
Wien: Springer. DOI: https://doi.org/10.1007/s00702-008-0077-9
Details DOI PMID PMC WoS

2009 | Journal Article
How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database
Baldwin, D. S.; Stein, D. J.; Dolberg, O. T. & Bandelow, B. (2009)
Human Psychopharmacology Clinical and Experimental, 24(4) pp. 269-275. DOI: https://doi.org/10.1002/hup.1019
Details DOI PMID PMC WoS

2010 | Conference Abstract
EVALUATION OF THE EFFECTS OF QUETIAPINE XR MONOTHERAPY ON SLEEP DISTURBANCE IN PATIENTS WITH MDD
Bandelow, B.; Demyttenaere, K.; Papakostas, G.; Trivedi, M. H.; Szamosi, J.; Earley, W. R. & Eriksson, H. (2010)
European Psychiatry, 25
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2010 | Journal Article
Update psychiatry - alcohol addiction anxiety disorders major-depressive disorder schizophrenia
Wobrock, T.; Bandelow, B.; Reinecke, U. H. & Wedekind, D. (2010)
NERVENHEILKUNDE, 29(11) pp. 734-+.
Details WoS

2010 | Conference Abstract
RATING SCALES AND STANDARDISED DIAGNOSTICS IN DAILY ROUTINE
Bandelow, B. (2010)
European Psychiatry, 25
Paris: Elsevier France-editions Scientifiques Medicales Elsevier.
Details WoS

2010 | Conference Abstract
Pooled analysis of the efficacy of adjunctive quetiapine XR in patients with major depressive disorder and high or low levels of baseline anxiety
Bandelow, B.; Bauer, M.; Vieta, E.; El-Khalili, N.; Udd, M.; Gustafsson, U. & Eriksson, H. (2010)
International Journal of Psychiatry in Clinical Practice, 14 pp. 19-20.
Oslo: Taylor & Francis As.
Details WoS

2010 | Conference Abstract
Efficacy of extended release quetiapine fumarate monotherapy in patients with generalised anxiety disorder : Results from 5 placebo-controlled trials
Stein, D.; Kalali, A.; Bandelow, B.; Katzman, M. A.; Olausson, B. & Eriksson, H. (2010)
The International Journal of Neuropsychopharmacology, 13 pp. 118-119. 27th CINP Congress Meeting 2010, Hong Kong, PEOPLES R CHINA.
New york: Cambridge Univ Press.
Details WoS

2010 | Conference Abstract
Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy on sleep disturbance in patients with major depressive disorder
Papakostas, G.; Bandelow, B.; Demyttenaere, K.; Trivedi, M. H.; Earley, W. R.; Szamosi, J. & Eriksson, H. (2010)
The International Journal of Neuropsychopharmacology, 13 27th CINP Congress Meeting 2010, Hong Kong, PEOPLES R CHINA.
New york: Cambridge Univ Press.
Details WoS

2010 | Conference Abstract
TREATMENT OF GENERALIZED ANXIETY DISORDER IN ROUTINE CLINICAL PRACTICE: AN INTERNATIONAL SURVEY
Baldwin, D. S.; Allgulander, C.; Bandelow, B.; Ferre, F. & Pallanti, S. (2010)
Journal of Psychopharmacology, 24 , Harrogate, ENGLAND.
London: Sage Publications Ltd.
Details WoS

2010 | Journal Article
Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study
Bandelow, B.; Chouinard, G.; Bobes, J.; Ahokas, A.; Eggens, I.; Liu, S. & Eriksson, H. (2010)
The International Journal of Neuropsychopharmacology, 13(3) pp. 305-320. DOI: https://doi.org/10.1017/S1461145709990423
Details DOI PMID PMC WoS

2010 | Journal Article
Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: A gender-specific effect?
Bandelow, B.; Saleh, K.; Pauls, J.; Domschke, K.; Wedekind, D. & Falkai, P. (2010)
The World Journal of Biological Psychiatry, 11(1) pp. 66-70. DOI: https://doi.org/10.3109/15622970701459810
Details DOI PMID PMC WoS

2010 | Journal Article
A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder
Wedekind, D.; Broocks, A.; Weiss, N.; Engel, K.; Neubert, K. & Bandelow, B. (2010)
The World Journal of Biological Psychiatry, 11(7) pp. 904-913. DOI: https://doi.org/10.3109/15622975.2010.489620
Details DOI PMID PMC WoS

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100